Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
UTR Therapeutics Inc. has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in May 2022.
UTR Therapeutics Inc.'s investors include Deerfield Management, New York City Economic Development Corporation - NYCEDC.
UTR Therapeutics Inc. is headquartered in New York, United States.
Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases
UTR Therapeutics Inc. is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"UTR Therapeutics Inc. — Funding & Investors." VCBacked, May 17, 2022, https://www.vcbacked.co/company/utr-therapeutics-inc. Accessed September 30, 2026.
VCBacked. (2022). UTR Therapeutics Inc. — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/utr-therapeutics-inc
{{cite web |title=UTR Therapeutics Inc. — Funding & Investors |url=https://www.vcbacked.co/company/utr-therapeutics-inc |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated